The demand for the widely used cancer drug Taxol is increasing, but it's difficult and expensive to produce because it hasn't been possible to do it biosynthetically. Until now, that is. Researchers ...

While President Donald Trump may wish he lives and works in the Hogwarts School of Witchcraft and Wizardry and has Harry ...

"Stacy is joining Upstream Bio at a pivotal time in our growth as we prepare to initiate a third clinical program for ...

Trump gives the impression that Americans will shortly see steep decreases in what they pay for prescription drugs. But even if the executive order acts as intended — which would require a lot to go ...

For years, Americans have been frustrated by the fact that they pay a lot more for medicines than people in virtually every ...

South Carolina Medicaid approved GLP-1s to treat obesity, placing it among the few state programs covering the drugs. But ...

CRISPR Therapeutics stock is down more than 80% from the peak it reached in 2021. The first drug from CRISPR Therapeutics ...

Feldman and Schor explain that the patent dance is a complex process to determine which of a biologic manufacturer’s patents ...

Generics maker Sandoz says president should focus on tactic of ‘evergreening’ pricier products in his drive to lower costs ...

Economists begin by asking what would happen in a completely free market. Then we ask whether government intervention of some ...

Importing foreign price controls via President Trump’s MFN scheme is not the answer. They risk patients access and ...

Presented by The Coalition to Strengthen America’s Healthcare — Rep. Ro Khanna (D-Calif.) introduced a bill codifying ...